Andromeda Robotics has sold about $30 million of equity toward a $75 million offering, according to a November 13 SEC filing, following an Australian care-home rollout and the launch of a California pilot for its Abi companion robot. The filing lists 17 investors and an October 29 first sale.

Care providers use Abi for conversations with residents and group activities such as singing and games. Andromeda says the robot recognizes people and remembers earlier conversations. In April, mecwacare and Andromeda announced that 22 Abis were installed across all 22 of the Australian operator’s residential care homes, serving more than 1,500 residents.

The equity sold already exceeds Andromeda’s September 2025 Series A, led by Forerunner Ventures and put at about $16 million by the Association for Advancing Automation. The association reported in June that the earlier round helped chief executive Grace Brown relocate from Melbourne to San Francisco.

In that interview, Brown said staff monitored Abi and could step in if needed. The company was also considering a shift from 3D-printed parts to injection molding as it sought to expand from dozens of deployed robots to thousands over two years.

Eskaton announced Abi’s California pilot at its Carmichael memory-care community on May 28. UC Davis nursing researchers designed a yearlong observational study there to follow up to 25 residents. “What we don’t know is what happens after the novelty fades,” principal investigator Roschelle Fritz said in the university’s May announcement.

Sources
1Andromeda Robotics — SEC Form D ↗
2SEC — filing date and document index ↗
3Andromeda — Abi capabilities and customer contracts ↗
4mecwacare — April 2026 deployment announcement ↗
5Association for Advancing Automation — June 2026 founder interview ↗
6Hamilton Locke — September 2025 Series A ↗
7Eskaton — California memory-care pilot ↗
8UC Davis — yearlong observational study ↗